Your location:Home page > Program
Zhi-Mei Huang
Share on:
Sun Yat-sen University Cancer Center, China

The Department of Minimally Invasive Interventional Therapy

Sun Yat-Sen University Cancer center

Secretary of the Department

Attending Physician


Clinical work

CT guided liver tumor ablation and interventional procedure more than 1,000 cases per year


Expertise

Expert in the combination of minimally invasive intervention and immunotherapy, targeted therapy for liver cancer. Expert in various types of solid tumor vascular intervention, ablation therapy, particle implantation therapy, stent implantation in various lumens, and biliary tract internal and external drainage surgery. 


Funded Grants in recent years

1.  Natural Science Foundation of Guangdong Province, “Study on the synergistic mechanism of TACE combined with LENVIMA and personalized neoantigen tumor vaccine in the treatment of advanced Hepatocellular carcinoma”Principal Investigator: Zhimei Huang, MD, ¥100,000.

2. One Bethune Foundation project and one Wu Jieping Foundation project, Principal Investigator: Zhimei Huang, MD, Total ¥150,000.


Research work

Main Publications in recent years(First auther/ Co-first auther/corresponding author/Co-corresponding author):10 (SCI:7)


Videos:0

Abstracts:2

245

0

0

Date Time Room Session Role Topic
2024-06-08 11:16-11:24 Meeting room - M1

Scientific Paper Session II

Speaker Modified TACE using low-dose chemotherapy with blank microspheres plus low-dose lenvatinib and microwave ablation for large (≥7 cm) unresectable HCC: The TALEM trial